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OBJECTIVE—To characterize birth size distribution in infants born to mothers with type 1
diabetes. In particular, the relationship between birth weight (BW) and length (BL) was studied
because it may provide information on different causal pathways of fetal macrosomia commonly
seen in diabetic pregnancies.
RESEARCH DESIGN AND METHODS—This was a population-based cohort study of
3,705 infants of type 1 diabetic mothers (1,876 boys), with a gestational age of 28–43 weeks,
born in Sweden between 1998 and 2007. BW and BL were retrieved from the Medical Birth
Registry and expressed as SD scores (SDS). Ponderal index (PI) was calculated as BW in g/length
in cm
3.AB W.90th and a PI #90th percentile was deﬁned as proportionate large-for-gestational
age (LGA), whereas if both BW and PI .90th percentile, the infant was categorized as dispropor-
tionately large. Values are mean (SD).
RESULTS—The BW distribution for offspring of type 1 diabetic mothers was bell-shaped,
signiﬁcantlybroader,andmarkedlyshiftedtotheright(BWSDS:1.27[1.48])ofthereference.Of
the infants born to diabetic mothers, 47% were LGA, and among them, 46% were dispropor-
tionately large compared with 35% in nondiabetic LGA infants (P , 0.001). Female offspring of
type 1 diabetic mothers had signiﬁcantly higher BWSDS than males (1.34 vs. 1.20, P , 0.01),
and preterm infants had higher BWSDS than term infants (1.41 vs. 1.23, P , 0.01)
CONCLUSIONS—Fetalmacrosomia intype 1diabeticpregnanciesisdueto aright-shiftand
broadening of the entire BW distribution. The large number of disproportionate LGA infants
born to type 1 diabetic mothers suggests an underlying metabolic problem. Fetal macrosomia
was more pronounced in preterm and female offspring of type 1 diabetic mothers.
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etal macrosomia is one of the most
frequent complications in the type 1
diabetic pregnancy. We have recently
reported a 31% incidence of large-for-
gestational age (LGA) infants, deﬁned as
birth weight (BW) .2 SD above the mean,
adjusted for gestational age (GA) and sex,
in a national cohort of more than 5,000
offspring of type 1 diabetic mothers in
Sweden between 1991 and 2003 (1).
Compared with data from 1982 to 1985
(2), the prevalence of LGA infants born to
mothers with type 1 diabetes has in-
creasedby50%.Highratesoffetalmacro-
somia in type 1 diabetic pregnancies have
also been reported from other European
countries (3).
High BW in offspring of type 1 di-
abetic mothers is associated with in-
creased risks of obstetric and perinatal
complications (4–6) as wellaswith future
risk of overweight, impaired glucose tol-
erance, cardiovascular disease, and dia-
betes (7–10). The increasing incidence
of fetal macrosomia in type 1 diabetic
pregnancies is therefore worrying and
warrants an explanation. The high inci-
dence of fetal macrosomia cannot only
be attributed to poor metabolic control
(1,2). In fact, the rate of fetal macrosomia
seems to remain high, despite apparently
good metabolic control (11).
Although there are several deﬁnitions
of fetal macrosomia, a shared limitation
with all current deﬁnitions of LGA is
that they do not distinguish between
normal and abnormal body composition.
In larger epidemiologic studies, a proxy
for body composition that can be used is
the relationship between the infant’sB W
and birth length (BL), expressed as the
ponderal index (PI) and calculated as
BW in g/length in cm
3. The LGA infant
may exhibit a proportionate relationship
between BW and BL or disproportionate
(i.e., high BW/BL ratio). Some have pro-
posed that proportionate largeness at
birth reﬂects constitutional and genetic
factors, whereas disproportionate large-
ness(i.e.,infantswithahighBW/BLratio)
reﬂects an abnormal intrauterine meta-
bolic environment (12). Accordingly, add-
ing analyses of proportionality to BW
distributions may provide important ad-
ditional information on different causal
p a t h w a y so ff e t a lm a c r o s o m i ai nt y p e1
diabetic pregnancies. A higher frequency
than normal of disproportionately large
infants (PI .90th percentile) has so far
been reported in two smaller series (n =
144 and 170) of offspring of type 1 dia-
betic mothers (6,13).
The primary aim of the current study
was to characterize the distributions of
BW, BL, and head circumferences (HC)
in a large, population-based cohort of
infants born to mothers with type 1 di-
abetes. A secondary aim was to determine
the proportion of these offspring who
were not only large at birth but also
overweight, deﬁned as a PI .90th per-
centile adjusted for GA and sex.
RESEARCH DESIGN AND
METHODS—This study used infor-
mation from the Swedish Medical Birth
Registry (MBR). The MBR prospectively
collects information on maternal demo-
graphics, clinical characteristics, and out-
comes for all mothers and their infants
discharged from Swedish maternity hos-
pitals and neonatal units. The MBR is reg-
ularly evaluated by the Swedish National
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ORIGINAL ARTICLEBoard of Health and covers .99% of all
pregnanciesinSweden.In1998,aquality
assurance check was preformed in which
581 original case records were compared
with the information in the MBR data-
base. The conclusion of this validation
was that most ﬁelds in the MBR are reli-
able (14).
In Sweden, there is free access to
antenatal care, and almost all women
comply with 7 to 10 visits to the midwife.
Women with type 1 diabetes are also fre-
quently seen throughout their pregnancy
by diabetes teams. Equipment for home
monitoring of blood glucose, insulin pens/
insulin pumps, and insulin are free of
charge.
Datingofpregnancyisbasedonarou-
tine ultrasound examination in the 16th
to the 18th postmenstrual week. At the
ﬁrst antenatal visit, the woman is inter-
viewed about her civil status, alcohol
consumption, smoking habits, and med-
icalandobstetrichistory.Maternalweight
and height, delivery, and perinatal data
are continuously entered into the MBR.
For this purpose, standardized individual
obstetricandneonatalformswith prospec-
tively deﬁned variables are used. Maternal
disease, complications during pregnancy
and delivery, as well as neonatal complica-
tions, are classiﬁed according to ICD-10.
Alldiagnosesaremadebyaphysicianbefore
hospital discharge, and copies of obstetric




study of all infants delivered by women
with type 1 diabetes, born alive after 28
to 43 weeks of gestation in Sweden be-
tween 1998 and 2007. Preterm birth was
deﬁned as delivery before 37 completed
weeks of gestation. Women with type 1
diabetes’ pregnancies were identiﬁed us-
ing ICD-10 code O 240. Stillborn infants,
multiple pregnancies, infants delivered
before 28 or after 43 completed weeks
of gestation, those with missing data on
B W ,B L ,s e x ,o rG A ,o rw i t haB W ,B L ,o r
HC.6SDaboveorbelowthemean,were
excluded from the study group. Infants
with major malformations (i.e., a mal-
formation considered fatal or potentially
life-threatening or that would likely lead
to a serious handicap if not surgically cor-
rected) were also excluded, as well as re-
cords with extreme values on maternal
age (,13 years), maternal weight (,40
or $200 kg), and maternal height (,120
or $200 cm).
Reference population and collection
and categorization of outcome
According to standardized operational
procedures, all infant anthropometrics
were measured within 12 h after birth.
BW was registered to the nearest gram
on an electronic scale; BL was measured
using a measuring board for length, and
tape measure was used for HC.
R e f e r e n c ed a t af o rn o r m a lf e t a l
growth were based on all singletons
born to mothers without type 1 diabetes
in our dataset. Exclusion criteria for the
reference group were multiple pregnan-
cies, stillborn infants, severe malforma-
tions, records with missing data on BW,
BL, GA, or sex, or with a BW, BL, or
HC.6SDaboveorbelowthemean.Also
excluded were records with extreme val-
ues on maternal age (,13 years), mater-
nal weight (,40 or $200 kg), and
maternal height (,120 or $200cm).Us-
ing this reference population, including
24 women with type 2 diabetes (0.003%)
and 8,929 women with gestational diabe-
tes(1%),weformedage-andsex-adjusted
percentiles for BW, BL, HC, and PI. The
SDS for BW, BL, and HC were also calcu-
lated by subtracting the reference mean
from the individual BW, BL, and HC val-
ues, respectively, and dividing this differ-
ence with the reference SD.
LGA was deﬁned as a BW .90th
percentile adjusted for GA and sex.
Appropriate-for-gestational age (AGA)
was deﬁned as a BW between the 10th and
90th percentile, and small-for-gestational
age (SGA) was a BW ,10th percentile in
the reference population. To discriminate
between proportionate and dispropor-
tionate fetal growth, PI was calculated
and a cutoff value was set at the 90th cus-
tomized percentile. A PI .90th percentile
was deﬁned as neonatal overweight. We
deﬁned proportionate LGA as a BW
.90th percentile together with a PI
#90th percentile and disproportionate
LGA as both a BW and a PI .90th per-
centile.
Maternal characteristics
Maternal characteristics included nation-
ality,deﬁnedasNordic(Sweden,Finland,
Denmark, Norway, and Island) or non-
Nordic, smoking habits during the ﬁrst
trimester of pregnancy, age, parity, pre-
pregnancy weight (kg), height (m), and
BMI. BMI was calculated as kg/m
2.
Statistical analyses
Data are presented as means (SD) and pro-
portions (%). PI and SDSs were calculated
for BW, BL, and HC. The Student t test,
Wilcoxon rank sum test, and x
2 test were
used for comparisons of group means and
proportions. Only infants with full data
on BW, BL, GA, and sex were included in
theanalysis.AvalueofP ,0.05wascon-
sidered statistically signiﬁcant. All statis-
tical analyses were performed using
STATA 10 SE software (StataCorp, College
Station, TX).
RESULTS
Study group and reference group
During the study period, there were
947,064 pregnancies, including 4,208
type 1 diabetic pregnancies. The ﬁnal
study cohort comprised 3,705 infants
(1,876 boys) of mothers with type 1 di-
abetes,excludingstillborninfants(0.81%),
multiple pregnancies (2.8%), infants with
major malformations (4.2%), those deliv-
ered before 28 (0.64%) or after 43 (0%)
completed weeks of gestation, and infants
with missing data on BW, BL, sex, or GA
(4.6%). No infants were excluded from
the study group because of values for BW,
BL,orHC.6SDaboveorbelowthemean.
Records of 883,163 infants (452,809
boys) were used as a reference for single-
ton fetal growth. Excluded from the
reference group were records of infants
of mothers with type 1 diabetes (0.44%);
were stillborn (0.31%); with major mal-
formations (1.84%); from multiple preg-
nancies (3.01%); with BW, BL, or HC .6
SD above or below the mean (0.1%); and
with missing data on BW, BL, GA, or sex
(1.65%).
Mothers with type 1 diabetes were
more often of Nordic origin and had a
signiﬁcantlyhighermeanBMIthanmoth-
ers in the reference group. There were no
signiﬁcantdifferencesinparityandsmok-
ing habits between mothers in the study
and reference groups. Despite a signiﬁ-
cantlylowermeanGAin thestudy group,
the mean BW was signiﬁcantly higher in
infants of mothers with type 1 diabetes
compared with the reference population.
BL and HC were not signiﬁcantly differ-
ent between the two groups. Maternal
and infant characteristics are presented
in Table 1.
Diabetes in pregnancy and size at
birth
Infants of mothers with type 1 diabetes
showed a normal (bell-shaped) BW dis-
tribution that was, however, signiﬁcantly
wider and markedly shifted to the right of
the normal reference (Fig. 1).
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Fetal macrosomia in type 1 diabetic pregnancyThemeanBWSDSofoffspringoftype
1 diabetic mothers was 1.27 (SD 1.48;
P , 0.001) compared with the reference
population. The BL distribution among
infants of mothers with type 1 diabetes
was also normal, broadened, and signiﬁ-
cantly shifted to the right of the normal
reference, with a mean BLSDS of 0.70
(1.22); that is, with a smaller right shift
than for BW, indicating disproportionate
fetal growth. The HCSDS distribution
was also right-shifted in the study cohort
(mean 0.57 [1.03]; P , 0.001) versus the
reference population, but not to the same
degree as for BW and BL (Table 1).
The proportion of LGA infants born
to mothers with type 1 diabetes was 47%.
In addition, 27% of offspring of type 1
diabetic mothers had a BW .97.5th per-
centile in the reference population; and
in 14%, the BW .4500 g. Three percent
of infants in the study group were SGA
(BW ,10th percentile) compared with
9.1% in the reference population.
The mean (SD) PI was signiﬁcantly
higherinoffspringoftype1diabeticmoth-
ers than in the reference population
(2.90 [0.33] vs. 2.76 [0.35] g/cm
3; P ,
0.001). In 30% of all infants of type 1
diabetic mothers, PI exceeded the 90th
percentile, and in diabetic LGA infants,
46% were disproportionately large at
birth, with a PI .90th percentile. The
corresponding proportions of neonatal
overweight (PI .90th percentile) were
10% in the overall reference population
and 35% among nondiabetic LGA in-
fants (Table 1).
Birth size in relation to GA
Preterm infants of mothers with type 1
diabetes had a signiﬁcantly higher mean
BWSDS(1.41vs.1.23)andBLSDS(0.80vs.
0.68) than infants born at term (P , 0.05
forbothcomparisons;Fig.2).Thepropor-
tionofLGA infants of mothers with type 1
diabetes was also signiﬁcantly larger in
preterm versus term infants (55.2 vs.
45.3%; P , 0.001). The average PI was
signiﬁcantly higher in term compared
with preterm infants of type 1 diabetic
mothers (2.93 vs. 2.78 g/cm
3; P , 0.001).
However,theproportion of infants of type
1 diabetic mothers with neonatal over-
weight (PI .90th percentile) was signiﬁ-
cantly larger in the preterm versus the
term group (36.5 vs. 28.4%; P , 0.001).
Among LGA infants there was no signiﬁ-
cant difference in the proportion of dis-
proportionate fetal growth in preterm
compared with term offspring of type 1
diabetic mothers.
Birth size in relation to sex
Girlsborntomotherswithtype1diabetes
had signiﬁcantly higher mean BWSDS
(1.34 vs. 1.20), BLSDS (0.76 vs. 0.65),
and HCSDS (0.62 vs. 0.53) compared
with boys (P , 0.01 for all comparisons;
Fig. 2). LGA was noted in 50% of girls
borntotype1diabeticmotherscompared
with 45% of boys (P = 0.003). The mean
PI was also signiﬁcantly higher in girls
born to type 1 diabetic mothers than in
boys (2.93 vs. 2.88 g/cm
3; P , 0.001),
but the number of disproportionate LGA
infants was similar in both sexes.
Birth size in relation to
maternal BMI
Mothers of disproportionate LGA infants
born at term had a signiﬁcantly higher
mean BMI than mothers who delivered
proportionate LGA infants at term. This
wastrueforthestudygroup(BMI26.6vs.
25.8 kg/m
2; P = 0.003) and the reference
population(BMI26.7vs.26.0kg/m
2;P,
0.001). The prevalence of maternal over-
weight (BMI .25 kg/m
2) was also signif-
icantly higher in disproportionate LGA
versus proportionate LGA infants born
a tt e r m ,i nb o t ht h es t u d y( 6 0 . 3v s .
54.3%; P = 0.03) and the reference group
(60.9 vs. 56.6%; P , 0.001). Among pre-
term infants, no relation was found be-
tween maternal BMI or the incidence of
maternal overweight and the proportion-
ality of their infants.
CONCLUSIONS—This study pres-
ents several important ﬁndings. First,
the distribution of BW, BL, and HC was
normalinnewborninfantsofmotherswith
type1diabetes.Second,alldistributions
Table 1—Maternal and infant characteristics for singleton pregnancies
Variable
Type 1 diabetes Reference population
P n = 3,705 n = 883,163
Maternal characteristics
Nordic origin 3,409 (92.0%) 736,327 (83.4%) ,0.001
Age (years) 30.4 (5.0) 30.0 (5.1) ,0.001
Prepregnancy weight (kg) 72.5 (13.6) 67.7 (12.8) ,0.001
Height (cm) 166.6 (6.3) 166.4 (6.3) 0.242
BMI (kg/m
2) 26.1 (4.7) 24.5 (4.4) ,0.001
Primipara 1,665 (44.9%) 389,430 (44.1%) 0.302
Smoking (ﬁrst trimester) 373 (10.1%) 81,502 (9.2%) 0.078
Infant characteristics
Gestational age (weeks) 37.7 (2.0) 39.4 (1.7) ,0.001
Male 1,876 (50.6%) 452,809 (51.3%) 0.44
BW (g) 3,775 (711) 3,570 (547) ,0.001
BW (SDS) 1.27 (1.5) 0.01 (1.0) ,0.001
BL (cm) 50.5 (2.8) 50.5 (2.4) 0.88
BL (SDS) 0.70 (1.2) 0.00 (1.0) ,0.001
HC (cm) 35.0 (1.8) 35.0 (1.7) 0.29
HC (SDS) 0.57 (1.0) 0.06 (1.0) ,0.001
LGA* 1,753 (47.3%) 87,283 (9.9%) ,0.001
PI (g/cm
3) 2.90 (0.3) 2.76 (0.4) ,0.001
PI .90th percentile 1,111 (30.0%) 91,173 (10.3%) ,0.001
Proportionately LGA 943 (25.5%) 56,634 (6.4%) ,0.001
Disproportionately LGA† 810 (21.9%) 30,649 (3.5%) ,0.001
Data are mean (SD) or n (%). *Birth weight .90th percentile. †BW and PI both .90th percentile.
Figure 1—Distribution of BWSDS in 3,705
infants born to type 1 diabetic mothers and in a
nondiabeticreferencepopulation (n = 883,163).
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Persson and Associateswere signiﬁcantly shifted to the right of
the normal reference, with the greatest
deviation for BW, resulting in 47% in-
cidence of fetal macrosomia (BW .90th
percentile). Third, 46% of the macrosomic
infants born to type 1 diabetic mothers
were disproportionately large (PI .90th
percentile) and could thus be considered
overweight at birth. However, the corre-
sponding proportion of disproportionate
growth in LGA infants of the reference
population without type 1 diabetes was
alsohigh(35%),implyingthatfactorsbe-
sidesmaternaldiabetesmaybeimportant
to explain fetal macrosomia in both dia-
betic and normal pregnancies. Finally,
the degree of fetal macrosomia was more
pronounced in female than in male off-
spring of type 1 diabetic mothers, and was
greater in preterm compared with term
infants.
The strength of the current study is
the population-based cohort, including a
large number of pregnancies complicated
by type 1 diabetes. This analysis offers
objective estimates of anthropometric
data in offspring of type 1 diabetic moth-
ers over a wide range of gestational ages.
The care of pregnant women with type 1
diabetes in Sweden is uniform. We know
fromourpreviousnationalstudyoftype1
diabeticpregnancies that majoroutcomes
do not vary with geographic area and
hospital size (1).
One limitation of the current study
is that the MBR does not contain data on
duration of diabetes, prevalence of pre-
existing microangiopathy, or glycemic
control during pregnancy. However, out-
comes of type 1 diabetic pregnancies in
Sweden have improved during the last 2
decades: the stillbirth rate decreased from
1.5% (1991 to 2003) to 0.81% (1998 to
2007, present study) (1). It is reasonable
to assume that this favorable outcome
over time can at least partly be attributed
to improved glycemic control.
We are aware of two previous studies
depicting the distribution of BWSDS in
offspring of type 1 diabetic mothers
(15,16). The ﬁnding in the current study
of a bell-shaped BWSDS distribution
with a mean of 1.27 is in line with earlier
ﬁndings.ThedistributionofBWwasmore
shiftedtotherightthanthecorresponding
BL distribution, indicating disproportion-
ate fetal growth. This ﬁnding is supported
by the higher mean PI in offspring of type
1 diabetic mothers (2.90 g/cm
3) versus in
the reference population (2.76 g/cm
3),
with 30% of infants in the study group
having a PI .90th percentile. Dispropor-
tionate fetal macrosomia was exhibited in
22% of all offspring of type 1 diabetic
mothers. This is in accordance with earlier
ﬁndings in smaller series of offspring of
type 1 diabetic mothers (6,13).
Fourty-six percent of LGA infants
had a disproportionate body constitution
with a high PI. Disproportionate macro-
somia is proposed to be mainly the result
of fetal hyperinsulinemia (12). Maternal
hyperglycemia is recognized to lead to
fetal hyperglycemia and hyperinsuline-
mia. Experimental and clinical studies
have shown that fetal hyperinsulinemia
is strongly associated with fetal macroso-
mia and increased adipose tissue mass
(17,18).
Maternal glucose values in type 1
diabetic pregnancies can only explain a
minor proportion of the variance in BW
(16,19). Furthermore, reported rates of
fetal macrosomia remain high, despite
tight glycemic control during pregnancy
(11,19). This, and the present ﬁnding of
ahighincidenceofdisproportionatemac-
rosomia also in the reference group, im-
plies that other factors besides maternal
hyperglycemia are important to explain
disproportionate fetal growth in type 1
diabetic and normal pregnancies.
In the recently published Hypergly-
caemia and Adverse Pregnancy Outcome
(HAPO) study of nondiabetic pregnan-
cies, maternal BMI was strongly associ-
ated with birth weight .90th percentile,
hyperinsulinemia, and fetal adiposity.
These associations were independent of
fasting and postload glucose values from
a 75-g oral glucose tolerance test early in
the third trimester (20). In the current
study, the mean maternal BMI and in-
cidence of maternal overweight were sig-
niﬁcantly higher in disproportionate
LGA compared with proportionate LGA
infants, born at term, in both the study
and reference group. The average BMI of
pregnant women has increased over time
in Sweden and has been demonstrated to
bean important contributing factor to the
increasing incidence of fetal macrosomia
in nondiabetic pregnancies (21). Taken
together, these ﬁndings support the effect
of BMI on fetal growth both in type 1 di-
abetic and nondiabetic pregnancies.
Ah i g hP Im a yr e ﬂect an increased lean
mass, fat mass, or both. The high mean PI
in our study cohort is most likely a reﬂec-
tion of primarily increased fat mass (17).
This hypothesis is supported by signiﬁ-
cantly higher cord blood concentrations
of insulin, C-peptide, and leptin in the off-
spring of type 1 diabetic mothers with a PI
.90th percentile compared with those
with a PI ,90th percentile (22).
An unexpected ﬁnding in the current
study was the signiﬁcantly higher values
of BWSDS in term and preterm girls born
to diabetic mothers. Studies of newborn
infants of nondiabetic mothers have
shown that term and preterm girls have
signiﬁcantly higher levels of insulin and
proinsulin in the cord blood and propor-
tionally greater amounts of body fat than
boys, despite a signiﬁcantly lower mean
absolute BW (23). The present ﬁnding of
signiﬁcantly higher PI values in female
offspring of type 1 diabetic mothers can
most likely be attributed to a greater ac-
cumulationoffatinthefemalethaninthe
male fetus. Cord blood concentrations of
C-peptide/insulin are much elevated in
the offspring of type 1 diabetic mothers,
Figure 2—SDSs for BW, BL,and HC inoffspring of type 1 diabetic mothers,stratiﬁedbysexand
gestational age. The bars show the mean values and the vertical lines indicate the SDs for the
SDSs.
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Fetal macrosomia in type 1 diabetic pregnancybut whether there is a sex difference is
unclear. One could, however, speculate
that hyperinsulinemia is more pro-
nounced in female than in male infants
of type 1 diabetic mothers.
Inlinewithpreviousﬁndings,55%of
the preterm infants were LGA (24). The
high BWSDS in preterm infants suggests
an early onset of enhanced fetal growth.
This is in accordance with ultrasound
measurements of fetal abdominal circum-
ference, showing growth deviation al-
ready in the second trimester of type 1
diabetic pregnancies (25). Poor glycemic
control in early pregnancy has been asso-
ciated with an increased risk of preterm
delivery (24). Furthermore, concentra-
tions of C-peptide in the cord blood are
signiﬁcantly higher in preterm than in
term offspring of type 1 diabetic mothers
(18).ThehighermeanBWSDSinpreterm
comparedwithterminfantscouldthusbe
an effect of maternal hyperglycemia in
early pregnancy that is more pronounced
than in women giving birth at term.
In conclusion, this study shows that
all anthropometric measures in the off-
spring of type 1 diabetic mothers are
signiﬁcantly shifted to the right of the
normal reference, which implies an early
onset of enhanced fetal growth. The
incidence of fetal macrosomia was very
high, and 46% of LGA infants were over-
weight at birth. The proportion of LGA
infants with a PI .90th percentile was
also high in the reference population.
The degree of fetal macrosomia was
more pronounced in preterm and female
offspring of type 1 diabetic mothers.
Other factors besides maternal over-
weight and maternal glycemic control
must be considered to explain the persis-
tently high rate of fetal macrosomia in
type 1 diabetic pregnancies.
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